Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
NVIDIA
NVDA
|
$1.23B |
| 2 |
Salesforce
CRM
|
$777M |
| 3 |
Flutter Entertainment
FLUT
|
$622M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$569M |
| 5 |
Amazon
AMZN
|
$566M |
Top Sells
| 1 |
Broadcom
AVGO
|
$1.95B |
| 2 |
MRO
Marathon Oil Corporation
MRO
|
$738M |
| 3 |
Alibaba
BABA
|
$328M |
| 4 |
Vistra
VST
|
$313M |
| 5 |
Wells Fargo
WFC
|
$265M |
Sector Composition
| 1 | Technology | 25.45% |
| 2 | Financials | 12.86% |
| 3 | Industrials | 11.54% |
| 4 | Consumer Discretionary | 10.57% |
| 5 | Healthcare | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3601
HF Foods Group
HFFG
$170M
| $39.6K | ﹤0.01% |
12,349
+1,572
| +15% | +$5.05K |
|
3602
Pyxis Oncology
PYXS
$118M
| $39.6K | ﹤0.01% |
25,366
+4,191
| +20% | +$6.54K |
|
3603
BRC Inc
BRCC
$174M
| $39.5K | ﹤0.01% |
12,445
+310
| +3% | +$983 |
|
3604
Dakota Gold
DC
$499M
| $39.4K | ﹤0.01% |
17,920
+1,409
| +9% | +$3.1K |
|
3605
CureVac
CVAC
$1.21B
| $39.4K | ﹤0.01% |
11,540
+14
| +0.1% | +$48 |
|
3606
Black Diamond Therapeutics
BDTX
$167M
| $39K | ﹤0.01% |
18,212
+732
| +4% | +$1.57K |
|
3607
Seres Therapeutics
MCRB
$169M
| $38.7K | ﹤0.01% |
2,329
-432
| -16% | -$7.18K |
|
3608
Nerdy
NRDY
$163M
| $38.7K | ﹤0.01% |
23,879
+627
| +3% | +$1.02K |
|
3609
Immunic
IMUX
$75.1M
| $36.8K | ﹤0.01% |
+36,811
| New | +$36.8K |
|
3610
Harvard Bioscience
HBIO
$21.3M
| $36.7K | ﹤0.01% |
17,404
+1,281
| +8% | +$2.7K |
|
3611
Cassava Sciences
SAVA
$104M
| $36.4K | ﹤0.01% |
15,408
-290,882
| -95% | -$686K |
|
|
SBDS
3612
Solo Brands, Inc.
SBDS
$18.8M
| $34.6K | ﹤0.01% |
30,325
+2,077
| +7% | +$2.37K |
|
3613
Acumen Pharmaceuticals
ABOS
$87.2M
| $34.1K | ﹤0.01% |
19,842
+1,653
| +9% | +$2.84K |
|
|
ADAP
3614
Adaptimmune Therapeutics
ADAP
$10.9M
| $34.1K | ﹤0.01% |
63,335
+28,526
| +82% | +$15.4K |
|
3615
AbCellera Biologics
ABCL
$1.26B
| $33K | ﹤0.01% |
11,253
+303
| +3% | +$888 |
|
3616
Verrica Pharmaceuticals
VRCA
$48.3M
| $31.6K | ﹤0.01% |
+4,513
| New | +$31.6K |
|
3617
ProQR Therapeutics
PRQR
$258M
| $31.5K | ﹤0.01% |
+11,887
| New | +$31.5K |
|
3618
GrowGeneration
GRWG
$90.3M
| $31.2K | ﹤0.01% |
18,485
+2,133
| +13% | +$3.61K |
|
3619
Lineage Cell Therapeutics
LCTX
$279M
| $31K | ﹤0.01% |
61,785
+1,272
| +2% | +$639 |
|
3620
Cabaletta Bio
CABA
$155M
| $30.6K | ﹤0.01% |
13,494
-371
| -3% | -$842 |
|
3621
Mammoth Energy Services
TUSK
$110M
| $30.4K | ﹤0.01% |
+10,122
| New | +$30.4K |
|
3622
FiscalNote
NOTE
$58.7M
| $30.2K | ﹤0.01% |
2,354
+43
| +2% | +$552 |
|
3623
Nautilus Biotechnolgy
NAUT
$83.5M
| $30K | ﹤0.01% |
17,881
-2,739
| -13% | -$4.6K |
|
3624
Nkarta
NKTX
$161M
| $29.9K | ﹤0.01% |
+11,997
| New | +$29.9K |
|
3625
Aclaris Therapeutics
ACRS
$227M
| $27.8K | ﹤0.01% |
+11,215
| New | +$27.8K |
|